# ANI Pharmaceuticals

ANI Pharmaceuticals is an Asset Manager based in Baudette, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Baudette, United States
- **Region:** North America
- **Address:** Baudette, MN, United States
- **Assets under management:** Undisclosed
- **Website:** anipharmaceuticals.com
- **LinkedIn:** https://www.linkedin.com/company/ani-pharmaceuticals-inc-

## Regulatory record

- **Reports private funds:** No

## About

ANI Pharmaceuticals is an integrated specialty pharmaceutical company developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals.

## Questions

### What investment posture does ANI Pharmaceuticals take toward its pipeline?

ANI operates as an operating company rather than an external allocator. It deploys balance-sheet capital primarily into acquiring Rare Disease products and optimizing manufactured generics. The company does not function as a fund or managed vehicle.

### How does ANI separate its Rare Disease business from its generics operations?

ANI reports through two distinct segments: Rare Disease and Generics & Others. The Rare Disease unit pursues medicines with limited patient populations and durable exclusivity periods. The Generics unit leverages the firm's manufacturing plant in Baudette to produce a broad portfolio of solid oral and liquid prescription products.

## Related profiles

- [Anhui Xiangchuan Private Equity Fund Management](https://altss.com/profile/anhui-xiangchuan-private-equity-fund-management)
- [Anova Technologies](https://altss.com/profile/anova-technologies)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/ani-pharmaceuticals

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology